Jaro, Jay Lanz G.
HRN: 05-60-55 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
CEFTRIAXONE 1G (VIAL)
11/22/2022
11/29/2022
IV
1g
Q12
Osteomyelitis
Waiting Final Action